Zobrazeno 1 - 10 of 338 pro vyhledávání: '"Silva-Arrieta S"'
1
Akademický článek
Vagus nerve dysfunction in the post-COVID-19 condition: a pilot cross-sectional study.
Autor: Lladós G; Department of Infectious Diseases, Germans Trias Long-COVID Unit, Fundació Lluita contra les Infeccions, Hospital Universitari Germans Trias i Pujol, Campus Can Ruti, Badalona, Spain; Red Española de la Investigación en COVID Persistente (REiCOP), Madrid, Spain; Universitat Autònoma de Barcelona (UAB), Bellaterra, Spain., Massanella M; IrsiCaixa AIDS Research Institute, Hospital Universitari Germans Trias i Pujol, Campus Can Ruti, Badalona, Spain; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas, CIBERINFEC, Madrid, Spain., Coll-Fernández R; Red Española de la Investigación en COVID Persistente (REiCOP), Madrid, Spain; Department of Rehabilitation, Hospital Universitari Germans Trias i Pujol, Campus Can Ruti, Badalona, Spain., Rodríguez R; Department of Radiology, Hospital Universitari Germans Trias i Pujol, Campus Can Ruti, Badalona, Spain., Hernández E; Department of Radiology, Hospital Universitari Germans Trias i Pujol, Campus Can Ruti, Badalona, Spain., Lucente G; Department of Neurology, Hospital Universitari Germans Trias i Pujol, Campus Can Ruti, Badalona, Spain., López C; Department of Infectious Diseases, Germans Trias Long-COVID Unit, Fundació Lluita contra les Infeccions, Hospital Universitari Germans Trias i Pujol, Campus Can Ruti, Badalona, Spain; Red Española de la Investigación en COVID Persistente (REiCOP), Madrid, Spain., Loste C; Department of Infectious Diseases, Germans Trias Long-COVID Unit, Fundació Lluita contra les Infeccions, Hospital Universitari Germans Trias i Pujol, Campus Can Ruti, Badalona, Spain; Red Española de la Investigación en COVID Persistente (REiCOP), Madrid, Spain; University of Vic-Central University of Catalonia (UVic-UCC), Vic, Catalonia, Spain., Santos JR; Department of Infectious Diseases, Germans Trias Long-COVID Unit, Fundació Lluita contra les Infeccions, Hospital Universitari Germans Trias i Pujol, Campus Can Ruti, Badalona, Spain; Red Española de la Investigación en COVID Persistente (REiCOP), Madrid, Spain., España-Cueto S; Department of Infectious Diseases, Germans Trias Long-COVID Unit, Fundació Lluita contra les Infeccions, Hospital Universitari Germans Trias i Pujol, Campus Can Ruti, Badalona, Spain., Nevot M; IrsiCaixa AIDS Research Institute, Hospital Universitari Germans Trias i Pujol, Campus Can Ruti, Badalona, Spain., Muñoz-López F; IrsiCaixa AIDS Research Institute, Hospital Universitari Germans Trias i Pujol, Campus Can Ruti, Badalona, Spain., Silva-Arrieta S; IrsiCaixa AIDS Research Institute, Hospital Universitari Germans Trias i Pujol, Campus Can Ruti, Badalona, Spain., Brander C; Universitat Autònoma de Barcelona (UAB), Bellaterra, Spain; IrsiCaixa AIDS Research Institute, Hospital Universitari Germans Trias i Pujol, Campus Can Ruti, Badalona, Spain., Durà MJ; Universitat Autònoma de Barcelona (UAB), Bellaterra, Spain; Department of Rehabilitation, Hospital Universitari Germans Trias i Pujol, Campus Can Ruti, Badalona, Spain., Cuadras P; Universitat Autònoma de Barcelona (UAB), Bellaterra, Spain; Department of Radiology, Hospital Universitari Germans Trias i Pujol, Campus Can Ruti, Badalona, Spain., Bechini J; Universitat Autònoma de Barcelona (UAB), Bellaterra, Spain; Department of Radiology, Hospital Universitari Germans Trias i Pujol, Campus Can Ruti, Badalona, Spain., Tenesa M; Department of Radiology, Hospital Universitari Germans Trias i Pujol, Campus Can Ruti, Badalona, Spain., Martinez-Piñeiro A; Department of Neurology, Hospital Universitari Germans Trias i Pujol, Campus Can Ruti, Badalona, Spain., Herrero C; Department of Infectious Diseases, Germans Trias Long-COVID Unit, Fundació Lluita contra les Infeccions, Hospital Universitari Germans Trias i Pujol, Campus Can Ruti, Badalona, Spain., Chamorro A; Department of Infectious Diseases, Germans Trias Long-COVID Unit, Fundació Lluita contra les Infeccions, Hospital Universitari Germans Trias i Pujol, Campus Can Ruti, Badalona, Spain., Garcia A; Department of Infectious Diseases, Germans Trias Long-COVID Unit, Fundació Lluita contra les Infeccions, Hospital Universitari Germans Trias i Pujol, Campus Can Ruti, Badalona, Spain., Grau E; IrsiCaixa AIDS Research Institute, Hospital Universitari Germans Trias i Pujol, Campus Can Ruti, Badalona, Spain; University of Vic-Central University of Catalonia (UVic-UCC), Vic, Catalonia, Spain., Clotet B; Department of Infectious Diseases, Germans Trias Long-COVID Unit, Fundació Lluita contra les Infeccions, Hospital Universitari Germans Trias i Pujol, Campus Can Ruti, Badalona, Spain; Universitat Autònoma de Barcelona (UAB), Bellaterra, Spain; IrsiCaixa AIDS Research Institute, Hospital Universitari Germans Trias i Pujol, Campus Can Ruti, Badalona, Spain; University of Vic-Central University of Catalonia (UVic-UCC), Vic, Catalonia, Spain., Paredes R; Department of Infectious Diseases, Germans Trias Long-COVID Unit, Fundació Lluita contra les Infeccions, Hospital Universitari Germans Trias i Pujol, Campus Can Ruti, Badalona, Spain; IrsiCaixa AIDS Research Institute, Hospital Universitari Germans Trias i Pujol, Campus Can Ruti, Badalona, Spain; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas, CIBERINFEC, Madrid, Spain; University of Vic-Central University of Catalonia (UVic-UCC), Vic, Catalonia, Spain; Center for Global Health and Diseases, Department of Pathology, Case Western Reserve University School of Medicine, Cleveland, OH, USA., Mateu L; Department of Infectious Diseases, Germans Trias Long-COVID Unit, Fundació Lluita contra les Infeccions, Hospital Universitari Germans Trias i Pujol, Campus Can Ruti, Badalona, Spain; Red Española de la Investigación en COVID Persistente (REiCOP), Madrid, Spain; Universitat Autònoma de Barcelona (UAB), Bellaterra, Spain; University of Vic-Central University of Catalonia (UVic-UCC), Vic, Catalonia, Spain. Electronic address: lmateu@lluita.org.
Publikováno v: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases [Clin Microbiol Infect] 2024 Apr; Vol. 30 (4), pp. 515-521. Date of Electronic Publication: 2023 Nov 19.
Zobrazit plný text záznamu
2
Akademický článek
Sirtuin-2, NAD-Dependent Deacetylase, Is a New Potential Therapeutic Target for HIV-1 Infection and HIV-Related Neurological Dysfunction.
Autor: Duran-Castells C; IrsiCaixa AIDS Research Institute, Hospital Germans Trias i Pujol, Badalona, Spain.; Departament de Biologia, Cel·lular, Fisiologia i d'immunologia, Facultat de Medicina, Universitat Autonoma de Barcelona, Cerdanyola del Valles, Spain., Llano A; IrsiCaixa AIDS Research Institute, Hospital Germans Trias i Pujol, Badalona, Spain., Kawana-Tachikawa A; AIDS Research Center, National Institute of Infectious Diseases, Tokyo, Japan., Prats A; Fundació Lluita contra la Sida and Infectious Diseases Department, Hospital Germans Trias i Pujol, Badalona, Spain., Martinez-Zalacain I; Department of Psychiatry, Bellvitge Biomedical Research Institute-IDIBELL, Barcelona, Spain., Kobayashi-Ishihara M; Department of Medicine and Life Sciences (MELIS), Universitat Pompeu Fabra, Barcelona, Spain., Oriol-Tordera B; IrsiCaixa AIDS Research Institute, Hospital Germans Trias i Pujol, Badalona, Spain.; Departament de Biologia, Cel·lular, Fisiologia i d'immunologia, Facultat de Medicina, Universitat Autonoma de Barcelona, Cerdanyola del Valles, Spain., Peña R; IrsiCaixa AIDS Research Institute, Hospital Germans Trias i Pujol, Badalona, Spain., Gálvez C; IrsiCaixa AIDS Research Institute, Hospital Germans Trias i Pujol, Badalona, Spain., Silva-Arrieta S; IrsiCaixa AIDS Research Institute, Hospital Germans Trias i Pujol, Badalona, Spain., Clotet B; IrsiCaixa AIDS Research Institute, Hospital Germans Trias i Pujol, Badalona, Spain.; Fundació Lluita contra la Sida and Infectious Diseases Department, Hospital Germans Trias i Pujol, Badalona, Spain.; Universitat de Vic - Universitat Central de Catalunya (UVic-UCC), Vic, Spain., Riveira-Muñoz E; IrsiCaixa AIDS Research Institute, Hospital Germans Trias i Pujol, Badalona, Spain., Ballana E; IrsiCaixa AIDS Research Institute, Hospital Germans Trias i Pujol, Badalona, Spain., Prado JG; IrsiCaixa AIDS Research Institute, Hospital Germans Trias i Pujol, Badalona, Spain.; Germans Trias i Pujol Research Institute (IGTP), Badalona, Spain.; CIBER Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain., Martinez-Picado J; IrsiCaixa AIDS Research Institute, Hospital Germans Trias i Pujol, Badalona, Spain.; Universitat de Vic - Universitat Central de Catalunya (UVic-UCC), Vic, Spain.; ICREA, Barcelona, Spain.; CIBER Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain., Sanchez J; Centro de Investigaciones Tecnologicas Biomedicas y Medioambientales, CITBM, Lima, Peru., Mothe B; IrsiCaixa AIDS Research Institute, Hospital Germans Trias i Pujol, Badalona, Spain.; Fundació Lluita contra la Sida and Infectious Diseases Department, Hospital Germans Trias i Pujol, Badalona, Spain.; Universitat de Vic - Universitat Central de Catalunya (UVic-UCC), Vic, Spain.; CIBER Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain., Hartigan-O'Connor D; Department of Medical Microbiology and Immunology, University of California, Davis, California, USA., Wyss-Coray T; Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, California, USA., Meyerhans A; Department of Medicine and Life Sciences (MELIS), Universitat Pompeu Fabra, Barcelona, Spain.; ICREA, Barcelona, Spain., Gisslén M; Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Region Västra Götaland, Sahlgrenska University Hospital, Department of Infectious Diseases, Gothenburg, Sweden., Price RW; Department of Neurology, University of California San Francisco, San Francisco, California, USA., Soriano-Mas C; Department of Psychiatry, Bellvitge Biomedical Research Institute-IDIBELL, Barcelona, Spain.; Department of Clinical Sciences, University of Barcelona, Barcelona, Spain.; Department of Psychobiology and Methodology in Health Sciences, Universitat Autònoma de Barcelona, Cerdanyola del Vallès, Spain., Muñoz-Moreno JA; Fundació Lluita contra la Sida and Infectious Diseases Department, Hospital Germans Trias i Pujol, Badalona, Spain.; Faculty of Psychology and Education Sciences, Universitat Oberta de Catalunya (UOC), Barcelona, Spain., Brander C; IrsiCaixa AIDS Research Institute, Hospital Germans Trias i Pujol, Badalona, Spain.; Universitat de Vic - Universitat Central de Catalunya (UVic-UCC), Vic, Spain.; ICREA, Barcelona, Spain.; CIBER Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain., Ruiz-Riol M; IrsiCaixa AIDS Research Institute, Hospital Germans Trias i Pujol, Badalona, Spain.; CIBER Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.
Publikováno v: Journal of virology [J Virol] 2023 Feb 28; Vol. 97 (2), pp. e0165522. Date of Electronic Publication: 2023 Jan 31.
Zobrazit plný text záznamu
3
Novel, in-natural-infection subdominant HIV-1 CD8+ T-cell epitopes revealed in human recipients of conserved-region T-cell vaccines
Autor: Borthwick, N, Lin, Z, Akahoshi, T, Llano, A, Silva-Arrieta, S, Ahmed, T, Dorrell, L, Brander, C, Murakoshi, H, Takiguchi, M, Hanke, T
Publikováno v: PLOS ONE
PLoS ONE
PLoS ONE, Vol 12, Iss 4, p e0176418 (2017)
Background Fine definition of targeted CD8+ T-cell epitopes and their human leucocyte antigen (HLA) class I restriction informs iterative improvements of HIV-1 T-cell vaccine designs and may predict early vaccine success or failure. Here, lymphocytes
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::b355fa7a0607ff90f4bde4ada19f9e50
https://doi.org/10.1371/journal.pone.0176418
Zobrazit plný text záznamu
4
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
5
Akademický článek
In silico veritas? Potential limitations for SARS-CoV-2 vaccine development based on T-cell epitope prediction.
Autor: Silva-Arrieta S; IrsiCaixa AIDS Research Institute, Hospital Germans Trias i Pujol, Institute for Health Science Research Germans Trias i Pujol (IGTP), Badalona, Spain., Goulder PJR; Department of Paediatrics, University of Oxford, Oxford, United Kingdom.; HIV Pathogenesis Programme, The Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa.; Ragon Institute of MGH, MIT, and Harvard, Cambridge, Massachusetts, United States of America., Brander C; IrsiCaixa AIDS Research Institute, Hospital Germans Trias i Pujol, Institute for Health Science Research Germans Trias i Pujol (IGTP), Badalona, Spain.; University of Vic-Central University of Catalonia, Catalonia, Vic, Spain.; Catalan Institution for Research and Advanced Studies (ICREA), Barcelona, Spain.
Publikováno v: PLoS pathogens [PLoS Pathog] 2020 Jun 04; Vol. 16 (6), pp. e1008607. Date of Electronic Publication: 2020 Jun 04 (Print Publication: 2020).
Zobrazit plný text záznamu
6
Akademický článek
Specificity of CD8 + T-Cell Responses Following Vaccination with Conserved Regions of HIV-1 in Nairobi, Kenya.
Autor: Mohamed YS; The Jenner Institute, University of Oxford, Oxford OX3 7DQ, UK.; Department of Microbiology and Immunology, Faculty of Pharmacy, Al-Azhar University, Cairo 11823, Egypt., Borthwick NJ; The Jenner Institute, University of Oxford, Oxford OX3 7DQ, UK., Moyo N; The Jenner Institute, University of Oxford, Oxford OX3 7DQ, UK., Murakoshi H; Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto 860-0811, Japan., Akahoshi T; Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto 860-0811, Japan., Siliquini F; The Jenner Institute, University of Oxford, Oxford OX3 7DQ, UK., Hannoun Z; The Jenner Institute, University of Oxford, Oxford OX3 7DQ, UK., Crook A; The Jenner Institute, University of Oxford, Oxford OX3 7DQ, UK., Hayes P; International AIDS Vaccine Initiative IAVI-Human Immunology Laboratory, Imperial College London, London SW10 9NH, UK., Fast PE; International AIDS Vaccine Initiative-New York, New York, NY 10004, USA., Mutua G; KAVI-Institute of Clinical Research, University of Nairobi, Nairobi 19676 00202, Kenya., Jaoko W; KAVI-Institute of Clinical Research, University of Nairobi, Nairobi 19676 00202, Kenya., Silva-Arrieta S; IrsiCaixa AIDS Research Institute-HIVACAT, Hospital Universitari Germans Trias i Pujol, 08916 Barcelona, Spain., Llano A; IrsiCaixa AIDS Research Institute-HIVACAT, Hospital Universitari Germans Trias i Pujol, 08916 Barcelona, Spain., Brander C; IrsiCaixa AIDS Research Institute-HIVACAT, Hospital Universitari Germans Trias i Pujol, 08916 Barcelona, Spain.; Faculty of Medicine, Universitat de Vic-Central de Catalunya (UVic-UCC), 08500 Vic, Spain.; Catalan Institution for Research and Advanced Studies (ICREA), 08010 Barcelona, Spain., Takiguchi M; Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto 860-0811, Japan., Hanke T; The Jenner Institute, University of Oxford, Oxford OX3 7DQ, UK.; Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto 860-0811, Japan.
Publikováno v: Vaccines [Vaccines (Basel)] 2020 May 29; Vol. 8 (2). Date of Electronic Publication: 2020 May 29.
Zobrazit plný text záznamu
7
Akademický článek
Drugs Targeting Sirtuin 2 Exhibit Broad-Spectrum Anti-Infective Activity.
Autor: Shenk, Thomas1,2 (AUTHOR) tshenk@princeton.edu, Kulp III, John L.3 (AUTHOR) john.kulp@coniferpoint.com, Chiang, Lillian W.1 (AUTHOR) lillian@evrysbio.com
Publikováno v: Pharmaceuticals (14248247). Oct2024, Vol. 17 Issue 10, p1298. 26p.
Zobrazit plný text záznamu
8
Akademický článek
Novel Nested Peptide Epitopes Recognized by CD4 + T Cells Induced by HIV-1 Conserved-Region Vaccines.
Autor: Borthwick N; The Jenner Institute, University of Oxford, Oxford OX3 7DQ, UK., Silva-Arrieta S; IrsiCaixa AIDS Research Institute-HIVACAT, Hospital Universitari Germans Trias i Pujol, 08916 Badalona, Barcelona, Spain., Llano A; IrsiCaixa AIDS Research Institute-HIVACAT, Hospital Universitari Germans Trias i Pujol, 08916 Badalona, Barcelona, Spain., Takiguchi M; Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto 860-0811, Japan., Brander C; IrsiCaixa AIDS Research Institute-HIVACAT, Hospital Universitari Germans Trias i Pujol, 08916 Badalona, Barcelona, Spain.; Faculty of Medicine, Universitat de Vic-Central de Catalunya (UVic-UCC), 08500 Vic, Spain.; Institució Catalana de Recerca I Estudis Avançats (ICREA), 08010 Barcelona, Spain., Hanke T; The Jenner Institute, University of Oxford, Oxford OX3 7DQ, UK.; Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto 860-0811, Japan.
Publikováno v: Vaccines [Vaccines (Basel)] 2020 Jan 16; Vol. 8 (1). Date of Electronic Publication: 2020 Jan 16.
Zobrazit plný text záznamu
9
Akademický článek
Development of a novel multi‑epitope vaccine against the pathogenic human polyomavirus V6/7 using reverse vaccinology.
Autor: Salahlou, Reza1,2 (AUTHOR), Farajnia, Safar1,3 (AUTHOR) farajnias@tbzmed.ac.ir, Bargahi, Nasrin1 (AUTHOR), Bakhtiyari, Nasim2,3 (AUTHOR), Elmi, Faranak4 (AUTHOR), Shahgolzari, Mehdi3 (AUTHOR), Fiering, Steven5 (AUTHOR), Venkataraman, Srividhya6 (AUTHOR)
Publikováno v: BMC Infectious Diseases. 2/9/2024, Vol. 24 Issue 1, p1-25. 25p.
Zobrazit plný text záznamu
10
Akademický článek
Immunoinformatics, molecular docking and dynamics simulation approaches unveil a multi epitope-based potent peptide vaccine candidate against avian leukosis virus.
Autor: Elshafei, Siham O.1 (AUTHOR), Mahmoud, Nuha A.1 (AUTHOR), Almofti, Yassir A.2 (AUTHOR) yamofti99@gmail.com
Publikováno v: Scientific Reports. 2/4/2024, Vol. 14 Issue 1, p1-22. 22p.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje